Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 February 1990:
Vol. 247. no. 4943, pp. 718 - 721
DOI: 10.1126/science.1689076
Prev | Table of Contents | Next

Articles

Science, Vol 247, Issue 4943, 718-721
Copyright © 1990 by American Association for the Advancement of Science

articles

T cells responsive to myelin basic protein in patients with multiple sclerosis

M Allegretta, JA Nicklas, S Sriram, and RJ Albertini

Genetics Laboratory, University of Vermont, Burlington 05401.

Gene mutation in vivo in human T lymphocytes appears to occur preferentially in dividing cells. Individuals with multiple sclerosis (MS) are assumed to have one or more populations of diving T cells that are being stimulated by autoantigens. Mutant T cell clones from MS patients were isolated and tested for reactivity to myelin basic protein, an antigen that is thought to participate in the induction of the disease. The hypoxanthine guanine phosphoribosyltransferase (hprt) clonal assay was used to determine mutant frequency values in MS patients with chronic progressive disease. Eleven of 258 thioguanine-resistant (hprt-) T cell clones from five of the six MS patients who were tested proliferated in response to human myelin basic protein without prior in vitro exposure to this antigen. No wild-type clones from these patients, nor any hprt- or wild-type clones from three healthy individuals responded to myelin basic protein. Thus, T cell clones that react with myelin basic protein can be isolated from the peripheral blood of MS patients.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.
Y. Yang, J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke (2009)
J. Exp. Med. 206, 1549-1564
   Abstract »    Full Text »    PDF »
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
D. T. Okuda, R. Srinivasan, J. R. Oksenberg, D. S. Goodin, S. E. Baranzini, A. Beheshtian, E. Waubant, S. S. Zamvil, D. Leppert, P. Qualley, et al. (2009)
Brain 132, 250-259
   Abstract »    Full Text »    PDF »
Distinct Functions of Autoreactive Memory and Effector CD4+ T Cells in Experimental Autoimmune Encephalomyelitis.
W. Elyaman, P. Kivisakk, J. Reddy, T. Chitnis, K. Raddassi, J. Imitola, E. Bradshaw, V. K. Kuchroo, H. Yagita, M. H. Sayegh, et al. (2008)
Am. J. Pathol. 173, 411-422
   Abstract »    Full Text »    PDF »
Increased CD8+ central memory T cells in patients with multiple sclerosis.
G.-Z. Liu, L.-B. Fang, P. Hjelmstrom, and X.-G. Gao (2007)
Multiple Sclerosis 13, 149-155
   Abstract »    PDF »
The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).
D. J. Araten and L. Luzzatto (2006)
Blood 108, 734-736
   Abstract »    Full Text »    PDF »
Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease.
A. M. Ercolini and S. D. Miller (2006)
J. Immunol. 176, 3293-3298
   Abstract »    Full Text »    PDF »
Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.
J. A. Traherne, L. F. Barcellos, S. J. Sawcer, A. Compston, P. P. Ramsay, S. L. Hauser, J. R. Oksenberg, and J. Trowsdale (2006)
Hum. Mol. Genet. 15, 155-161
   Abstract »    Full Text »    PDF »
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
D N Bourdette, E Edmonds, C Smith, J D Bowen, C R. Guttmann, Z P Nagy, J Simon, R Whitham, J Lovera, V Yadav, et al. (2005)
Multiple Sclerosis 11, 552-561
   Abstract »    PDF »
CD4+ regulatory cells as a potential immunotherapy.
Z. Fehervari and S. Sakaguchi (2005)
Phil Trans R Soc B 360, 1647-1661
   Abstract »    Full Text »    PDF »
Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions.
E. M. Frohman, M. Filippi, O. Stuve, S. G. Waxman, J. Corboy, J. T. Phillips, C. Lucchinetti, J. Wilken, N. Karandikar, B. Hemmer, et al. (2005)
Arch Neurol 62, 1345-1356
   Abstract »    Full Text »    PDF »
Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing-remitting multiple sclerosis patients.
I R Moldovan, R A Rudick, A C Cotleur, S E Born, J-C Lee, M T Karafa, and C M Pelfrey (2005)
Multiple Sclerosis 11, 251-260
   Abstract »    PDF »
Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.
J. N. H. Stern, Z. Illes, J. Reddy, D. B. Keskin, M. Fridkis-Hareli, V. K. Kuchroo, and J. L. Strominger (2005)
PNAS 102, 1620-1625
   Abstract »    Full Text »    PDF »
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines.
R. Hohlfeld and H. Wekerle (2004)
PNAS 101, 14599-14606
   Abstract »    Full Text »    PDF »
The regulatory role of natural killer cells in multiple sclerosis.
K. Takahashi, T. Aranami, M. Endoh, S. Miyake, and T. Yamamura (2004)
Brain 127, 1917-1927
   Abstract »    Full Text »    PDF »
Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells.
Z. Illes, J. N. H. Stern, J. Reddy, H. Waldner, M. P. Mycko, C. F. Brosnan, S. Ellmerich, D. M. Altmann, L. Santambrogio, J. L. Strominger, et al. (2004)
PNAS 101, 11749-11754
   Abstract »    Full Text »    PDF »
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.
M. P. Crawford, S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt, D. A. Price, P. Stastny, D. C. Douek, R. A. Koup, M. K. Racke, et al. (2004)
Blood 103, 4222-4231
   Abstract »    Full Text »    PDF »
Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.
W. Sun, U. Popat, G. Hutton, Y. C. Q. Zang, R. Krance, G. Carrum, G. A. Land, H. Heslop, M. Brenner, and J. Z. Zhang (2004)
Brain 127, 996-1008
   Abstract »    Full Text »    PDF »
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis.
Y. C. Q. Zang, S. Li, V. M. Rivera, J. Hong, R. R. Robinson, W. T. Breitbach, J. Killian, and J. Z. Zhang (2004)
J. Immunol. 172, 5120-5127
   Abstract »    Full Text »    PDF »
Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis.
B. Bielekova, M.-H. Sung, N. Kadom, R. Simon, H. McFarland, and R. Martin (2004)
J. Immunol. 172, 3893-3904
   Abstract »    Full Text »    PDF »
Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
Y. C. Q. Zang, J. Hong, V. M. Rivera, J. Killian, and J. Z. Zhang (2003)
Int. Immunol. 15, 1073-1080
   Abstract »    Full Text »    PDF »
The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents.
K. V. Toyka and R. Gold (2003)
Neurology 60, S2-7
   Abstract »    Full Text »
Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis.
D. C. Mohr, D. E. Goodkin, J. Islar, S. L. Hauser, and C. P. Genain (2001)
Arch Neurol 58, 1081-1086
   Abstract »    Full Text »    PDF »
Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression.
Y.-M. Huang, M. Kouwenhoven, Y.-P. Jin, R. Press, W.-X. Huang, and H. Link (2001)
Multiple Sclerosis 7, 95-99
   Abstract »    PDF »
Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis.
M. V. Tejada-Simon, Y. C. Q. Zang, D. Yang, J. Hong, S. Li, R. A. K. Singh, E. Van den Berg-Loonen, J. M. Killian, V. M. Rivera, and J. Z. Zhang (2000)
Int. Immunol. 12, 1641-1650
   Abstract »    Full Text »    PDF »
Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients.
K G Warren and I. Catz (2000)
Multiple Sclerosis 6, 300-311
   Abstract »    PDF »
Aberrant T cell migration toward RANTES and MIP-1{alpha} in patients with multiple sclerosis: Overexpression of chemokine receptor CCR5.
Y. C. Q. Zang, A. K. Samanta, J. B. Halder, J. Hong, M. V. Tejada-Simon, V. M. Rivera, and J. Z. Zhang (2000)
Brain 123, 1874-1882
   Abstract »    Full Text »    PDF »
Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.
Y. C. Q. Zang, D. Yang, J. Hong, M. V. Tejada-Simon, V. M. Rivera, and J. Z. Zhang (2000)
Neurology 55, 397-404
   Abstract »    Full Text »    PDF »
Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity.
P. A. Muraro, M. Pette, B. Bielekova, H. F. McFarland, and R. Martin (2000)
J. Immunol. 164, 5474-5481
   Abstract »    Full Text »    PDF »
Visualization of Myelin Basic Protein (MBP) T Cell Epitopes in Multiple Sclerosis Lesions using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (HLA)-DR2-MBP 85-99 Complex.
M. Krogsgaard, K. W. Wucherpfennig, B. Canella, B. E. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C. Raine, J. Engberg, and L. Fugger (2000)
J. Exp. Med. 191, 1395-1412
   Abstract »    Full Text »    PDF »
Identification of Pathogenic T Cells in Patients with Beryllium-Induced Lung Disease.
A. P. Fontenot, M. T. Falta, B. M. Freed, L. S. Newman, and B. L. Kotzin (1999)
J. Immunol. 163, 1019-1026
   Abstract »    Full Text »    PDF »
Presentation of the Self Antigen Myelin Basic Protein by Dendritic Cells Leads to Experimental Autoimmune Encephalomyelitis.
B. N. Dittel, I. Visintin, R. M. Merchant, and C. A. Janeway Jr. (1999)
J. Immunol. 163, 32-39
   Abstract »    Full Text »    PDF »
Candidate autoantigens in multiple sclerosis.
S. Schmidt (1999)
Multiple Sclerosis 5, 147-160
   Abstract »    PDF »
Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies.
M Spadaro, M A Amendolea, M G Mazzucconi, R Fantozzi, R Di Lello, P Zangari, and C Masala (1999)
Multiple Sclerosis 5, 121-125
   Abstract »    PDF »
Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.
M. Yoshioka, P. M. Vacek, T. Poseno, R. Silver, and B. A. Finette (1999)
PNAS 96, 586-591
   Abstract »    Full Text »    PDF »
Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein.
K. J. Smith, J. Pyrdol, L. Gauthier, D. C. Wiley, and K. W. Wucherpfennig (1998)
J. Exp. Med. 188, 1511-1520
   Abstract »    Full Text »    PDF »
Selective Accumulation of Related CD4+ T Cell Clones in the Synovial Fluid of Patients with Rheumatoid Arthritis.
C. C. Striebich, M. T. Falta, Y. Wang, J. Bill, and B. L. Kotzin (1998)
J. Immunol. 161, 4428-4436
   Abstract »    Full Text »    PDF »
Immunity to T Cell Receptor Peptides in Multiple Sclerosis. III. Preferential Immunogenicity of Complementarity-Determining Region 2 Peptides from Disease-Associated T Cell Receptor BV Genes.
D. N. Bourdette, Y. K. Chou, R. H. Whitham, J. Buckner, H. J. Kwon, G. T. Nepom, A. Buenafe, S. A. Cooper, M. Allegretta, G. A. Hashim, et al. (1998)
J. Immunol. 161, 1034-1044
   Abstract »    Full Text »    PDF »
Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
P. Stinissen, R. Medaer, and J. Raus (1998)
Multiple Sclerosis 4, 203-211
   Abstract »    PDF »
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation.
C. Scholz, K. T. Patton, D. E. Anderson, G. J. Freeman, and D. A. Hafler (1998)
J. Immunol. 160, 1532-1538
   Abstract »    Full Text »    PDF »
CD8+ Myelin Peptide-Specific T Cells Can Chemoattract CD4+ Myelin Peptide-Specific T Cells: Importance of IFN-Inducible Protein 10.
W. E. Biddison, W. W. Cruikshank, D. M. Center, C. M. Pelfrey, D. D. Taub, and R. V. Turner (1998)
J. Immunol. 160, 444-448
   Abstract »    Full Text »    PDF »
Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease.
K. D. Bieganowska, L. J. Ausubel, Y. Modabber, E. Slovik, W. Messersmith, and D. A. Hafler (1997)
J. Exp. Med. 185, 1585-1594
   Abstract »    Full Text »    PDF »
Frequency of Hypoxanthine Guanine Phosphoribosyltransferase (HPRT-) T Cells in the Peripheral Blood of Cardiac Transplant Recipients : A Noninvasive Technique for the Diagnosis of Allograft Rejection.
A. A. Ansari, A. Mayne, J. B. Sundstrom, M. B. Gravanis, K. Kanter, K. W. Sell, F. Villinger, C. O. Siu, and A. Herskowitz (1995)
Circulation 92, 862-874
   Abstract »    Full Text »
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
J Zhang, R Medaer, P Stinissen, D Hafler, and J Raus (1993)
Science 261, 1451-1454
   Abstract »    PDF »
Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.
K. Wucherpfennig, K Ota, N Endo, J. Seidman, A Rosenzweig, H. Weiner, and D. Hafler (1990)
Science 248, 1016-1019
   Abstract »    PDF »
NEW EVIDENCE SUPPORTS AN IMMUNE THEORY OF MULTIPLE SCLEROSIS.
(1990)
Journal Watch (General) 1990, 5
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)